Global demand for Balloon Catheters is expected to increase at a CAGR of 4% from 2022 to 2032, reaching a valuation of US$ 5.47 Mn by 2032. Future Market Insights provides in-depth analysis and insights into the global balloon catheter market and studies the factors and restraints impacting the market during the forecast period.
According to Future Market Insights, a rising prevalence of cardiac diseases leading to interventional cardiology procedures and an increasing geriatric population prone to cardiac arrest is expected to fuel the growth of the global balloon catheter market over the forecast period. "Economic factors such as growing healthcare expenditure, increasing disposable income per capita, rising government support in developed economies, and favourable reimbursement policies are expected to boost the growth of the global balloon catheter market over the forecast period." Analyst, Future Market Insights.
However, a high cost of coronary angioplasty and stenting treatment and risk of infection and artery collapse associated with balloon catheterisation is likely to hinder market growth over the forecast period.
The global balloon catheter market is segmented on the basis of product type (Normal Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Drug Eluting Balloon Catheter, Stent Graft Balloon Catheter); disease indication (Coronary Artery Disease, Peripheral Vascular Disease); raw material (Polyurethane, Nylon, Others); and end user (Public Hospitals & Private Hospitals, Ambulatory Surgical Centres, Cardiac Catheterisation Laboratories).
Vendor insights
Boston Scientific Inc., Medtronic, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Jotech GmbH, QX Medical LLC, Meril Life Pvt. Ltd., Hexacath, Abbott Laboratories, Tokai Medical Products Inc., Biosensors International Ltd., Cook Medical Inc., Cardionovum GmbH, Cordis Corporation, and Biotronik Inc. are the leading companies operating in the global balloon catheter market. Major market players are adopting strategies such as mergers and acquisitions to maintain their market share.
Browse More@ https://www.futuremarketinsights.com/reports/balloon-catheter-market
This report studies the global market size of Normal BalloonCatheters in keyregions like North America, Europe, Asia Pacific, Central & South Americaand Middle East & Africa, focuses on the consumption of Normal BalloonCatheters inthese regions.
This report also studies the global market status, competitionlandscape, market share, growth rate, future trends, market drivers,opportunities and challenges, sales channels, distributors and Porter’s FiveForces Analysis.
The objectives ofthis study are to define, segment, and project the size of the Normal BalloonCatheters marketbased on company, product type, application and key regions.
Market size split by Region
Rest of Central & South America
The study objectives of this report are:
Balloon Catheters Market InsightsBalloon catheter is a flexible device with a balloon at its tip, which may be inflated or deflated when the catheter is in place to create or enlarge a passageway, and it is also used to remove the blockage or open the narrowed coronary arteries caused by coronary arteries disease.
Furthermore, the balloon catheters have applications in renal denervation, cryoablation, drug delivery, perfusion, and atherectomy.According to the stats published by The Heart Foundation in 2015, coronary artery disease leads to around 380,000 fatalities annually in the U.S.
Moreover, according to the same source, around 720,000 people suffer from heart attacks each year and among these, 205,000 encountered repetitive cases of heart attack and 515,000 people suffered from a first incidence of heart attack in the U.S.The global balloon catheters market was valued at US$ 11,463.0 million in 2018, and is expected to exhibit a CAGR of 5.3% during the forecast period (2019 – 2027).Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/489Increasing product launches of innovative balloon catheters by key players for the treatment of the coronary heart diseases and peripheral heart diseases is expected to drive growth of the balloon catheters market over the forecast periodManufacturers are focusing on product development and product launches of different types of balloon catheters such as over-the-wire, rapid exchange, fixed wire, drug eluting balloon catheters, and drug coated balloon catheters.
Moreover, in April 2015, Biotronik launched Pantera Pro, a semi-compliant coronary balloon dilatation catheter.Adoption of inorganic strategies by major players in the balloon catheters market is expected to drive market growthMajor players are focused on adopting inorganic strategies such as collaborations, in order to strengthen the balloon catheter product portfolio by launching novel balloon catheters, which is expected to drive the global balloon catheters market growth over the forecast period.
For instance, in September 2014, NATEC Medical Ltd collaborated with US Endovascular LLC, a medical device company, to deliver the range of PTA balloon catheters, developed by the US Endovascular, in the U.S. market.
The PTA balloon platforms includes balloon catheters such as USE 014” Rapid Exchange (Rx) and Over the Wire (OTW), USE018” OTW, and USE 035” OTW.However, increasing product recall is expected to hamper growth of the balloon catheters market over the forecast period.
